STOCK TITAN

Takeda (NYSE: TAK) director Koji Hatsukawa details shares, RSUs and tax awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

TAKEDA PHARMACEUTICAL CO LTD director Koji Hatsukawa filed an initial ownership report showing equity and award holdings in the company. He directly holds 25,834 Ordinary Shares.

He also holds several Tax Obligation Awards, each economically equivalent to one Ordinary Share and intended to be settled in cash at vesting primarily to cover tax obligations. These awards reference 2,152, 2,392, 2,280 and 2,318 underlying Ordinary Shares, with scheduled vesting or expiration dates between June 1, 2026 and June 1, 2028 or upon conclusion of board service.

In addition, the holdings include an award of 8,600 restricted stock units, each representing a contingent right to receive one Ordinary Share. These RSUs vest in tranches of 2,100, 2,200, and 2,100 shares on June 1, 2026, 2027 and 2028, with a final 2,200-share tranche vesting upon retirement from board service.

Positive

  • None.

Negative

  • None.
Insider Hatsukawa Koji
Role Director
Type Security Shares Price Value
holding Tax Obligation Award -- -- --
holding Tax Obligation Award -- -- --
holding Tax Obligation Award -- -- --
holding Tax Obligation Award -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Tax Obligation Award — 2,152 shares (Direct); Ordinary Shares — 25,834 shares (Direct)
Footnotes (1)
  1. Includes an award of 8,600 restricted stock units (RSUs). Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest on the following schedule: June 1, 2026 (2,100 shares), June 1, 2027 (2,200 shares), June 1, 2028 (2,100 shares) and upon retirement from board service (2,200 shares). Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Vests upon conclusion of the director's service on the board.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Hatsukawa Koji

(Last)(First)(Middle)
2-27 FUJIMIGAOKA, TSUZUKI-KU
YOKOHAMA

(Street)
KANAGAWA224-0051

(City)(State)(Zip)

JAPAN

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares25,834(1)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Tax Obligation Award06/01/202606/01/2026Ordinary Shares2,152(2)D
Tax Obligation Award06/01/202706/01/2027Ordinary Shares2,392(2)D
Tax Obligation Award06/01/202806/01/2028Ordinary Shares2,280(2)D
Tax Obligation Award (3) (3)Ordinary Shares2,318(2)D
Explanation of Responses:
1. Includes an award of 8,600 restricted stock units (RSUs). Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest on the following schedule: June 1, 2026 (2,100 shares), June 1, 2027 (2,200 shares), June 1, 2028 (2,100 shares) and upon retirement from board service (2,200 shares).
2. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
3. Vests upon conclusion of the director's service on the board.
Remarks:
Exhibit 24 Power of Attorney
/s/ Max Heuer, by power of attorney, for Koji Hatsukawa03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Koji Hatsukawa report owning in Takeda (TAK) on this Form 3?

Koji Hatsukawa reports direct ownership of 25,834 Ordinary Shares of Takeda. He also holds several Tax Obligation Awards tied to Ordinary Shares and an additional award of 8,600 restricted stock units, which may convert into Ordinary Shares as they vest over time.

How many restricted stock units does Koji Hatsukawa hold in Takeda (TAK)?

He holds an award of 8,600 restricted stock units (RSUs). Each RSU represents a contingent right to receive one Ordinary Share, vesting in scheduled tranches between June 1, 2026 and June 1, 2028, with a final tranche vesting upon retirement from board service.

What are the Tax Obligation Awards reported by Koji Hatsukawa in Takeda (TAK)?

The Tax Obligation Awards are instruments economically equivalent to one Ordinary Share each. Upon vesting, they convert into cash payments primarily to cover tax obligations, based on the then-current market price of Takeda’s Ordinary Shares, rather than delivering additional shares to the director.

What underlying share amounts are tied to Koji Hatsukawa’s Tax Obligation Awards in Takeda (TAK)?

His Tax Obligation Awards reference 2,152, 2,392, 2,280 and 2,318 underlying Ordinary Shares. These amounts correspond to awards with vesting or expiration dates from June 1, 2026 through June 1, 2028 or upon conclusion of his board service.

Does this Takeda (TAK) Form 3 show Koji Hatsukawa buying or selling shares?

The Form 3 identifies holdings rather than explicit purchases or sales. It lists existing Ordinary Shares, Tax Obligation Awards, and restricted stock units. Transaction codes and directions are shown as unknown, indicating this filing is primarily an initial ownership snapshot, not a record of new trades.

How do Koji Hatsukawa’s RSUs in Takeda (TAK) vest over time?

His 8,600 RSUs vest in four parts: 2,100 shares on June 1, 2026; 2,200 shares on June 1, 2027; 2,100 shares on June 1, 2028; and a final 2,200-share tranche that vests when he retires from Takeda’s board.
Takeda Pharm

NYSE:TAK

View TAK Stock Overview

TAK Rankings

TAK Latest News

TAK Latest SEC Filings

TAK Stock Data

57.06B
3.16B
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Japan
Tokyo